Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Omicron

US Government Calls For Additional Doses Of Pfizer/BioNTech COVID-19 Vaccine

Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have announced a new vaccine supply agreement with the U.S. government. Under the agreement, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg). This may include adult omicron-adapted COVID-19 vaccines, subject to the FDA authorization. The doses are planned to be delivered…

Benzinga

COVID vaccination reboot coming this fall to add tweaks for new coronavirus variants

The FDA will have to decide the exact recipe. But expect a combination shot that adds protection against omicron or some of its newer relatives to the original vaccine.

Chicago Sun-Times

Jason Leitch 'concerned' over rise in covid cases as he issues face covering guidance

The latest figures published on Friday by the Office for National Statistics revealed that one in 20 people in Scotland currently have the virus.

Daily Record

From analysis to the latest developments in health,
read the most diverse news in one place.

Schools alarm as Covid is blamed for 25% rise in number absent

Teachers have issued a Covid warning after the number of children off school rose by a quarter in two weeks.

Evening Standard

What are the symptoms of the BA4 and BA5 Omicron variants and how widespread are they?

BA.4 and BA.5 have already triggered a rise in infections in the UK, with experts warning that the country is already in the midst of its fifth coronavirus wave with nearly 300,000 people infected each day

Daily Mirror

UK Covid cases surge towards 300,000 PER DAY with one in 21 Brits now infected

Recent weeks has seen a resurgence amongst case rates for Covid as an omicron subvariant powers the spread across the UK despite it being summer time

Daily Mirror

How the UK’s rising Covid cases compare to other countries

Omicron sub-variants driving up infections in 110 nations, WHO director-general warns

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Most infectious Covid variants as Omicron fuels rise in UK cases

How the most common of the 11 variants compare

The Independent UK

Covid incubation period: How long are you infectious for?

Experts warn of fifth wave of infections as hospital admissions rise

The Independent UK

Covid: Do you still need to wear a face mask?

Requirement to wear coverings in certain spaces dropped as part of government’s ‘Living with Covid’ strategy but increasingly advisable as cases rise

The Independent UK

Covid self-isolation rules: Do you need to isolate?

Current guidance means public no longer legally required to enter quarantine but doing so advisable for safety of others, particularly as cases rise

The Independent UK

When can I get my Covid booster jab? Everything you need to know

Experts warn fifth wave of coronavirus infections underway as hospital admissions rise

The Independent UK

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Most reported covid symptom affects the head as cases soar

The increase is being driven by the recent BA.4 and BA.5 subvariants of Omicron

Liverpool Echo

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'

The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall. The news, announced Tuesday, June 28, could have a big impact on the share prices of vaccine makers.

Benzinga

Revive Therapeutics Data Access Plan Approved By The FDA; Partial Unblinded Data In Company Hands

Revive Therapeutics Ltd. (OTC: RVVTF) moved closer towards potential endpoint change in their Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat COVID-19.

Dublin Live

Covid-19: Professor Luke O'Neill says it is 'likely' new Omicron vaccine could be given with flu jab

There are 776 people in hospital with the virus on Wednesday

The Independent UK

How the UK’s rising COVID cases compare to other countries

Omicron sub-variants driving up infections in 110 nations, WHO director-general warns

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

A viral reprise: When COVID-19 strikes again and again

Medical experts warn that repeated COVID-19 infections are getting more likely as the pandemic drags on and the coronavirus evolves

Axios

COVID vaccine strategy still murky after FDA experts meet

The Independent UK

Most infectious Covid variants as Omicron fuels rise in UK cases

How the most common of the 11 variants compare

The Independent UK

Covid reinfections: How likely are you to catch coronavirus again as cases rise?

Do vaccines and booster shots protect against new variants? Here’s what you need to know

The Independent UK

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Covid incubation period: How long are you infectious for?

Experts warn of fifth wave of infections as hospital admissions rise

The Independent UK

Covid: Do you still need to wear a face mask?

Requirement to wear coverings in certain spaces dropped as part of government’s ‘Living with Covid’ strategy but increasingly advisable as cases rise

1 … 52 53 54 55

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

UK Health Security Agency

485 stories

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.